Outcomes of patients with pelvic leiomyosarcoma treated by surgery and relevant auxiliary diagnosis

Table 1 Basic demographic characteristics of patients

Characteristic	Uterine leiomyosarcoma (n = 35)	Non-uterine leiomyosarcoma (n = 16)
Age [mean (range)], yr	49.6 (32-71)	46.0 (29-66)
Menopause, n (%)
No	21 (60)	9 (56.3)
Yes	14 (40)	7 (43.7)
Medical disease, n (%)
Hypertension	6 (17.1)	2 (12.5)
Diabetes mellitus	1 (2.9)	2 (12.5)
History of operation, n (%)
Hysteromyoma surgery	20 (57.1)	6 (37.5)
Cesarean section	5 (14.3)	3 (18.8)
Other abdominal surgeries1	8 (22.9)	6 (37.5)
Clinical symptoms, n (%)
Menorrhagia and menstrual disorder	9 (25.7)	0 (0)
Abdominal pain and abdominal distention	6 (17.1)	8 (50)
Palpable mass	2 (5.7)	1 (6.25)
Limb pain	0 (0)	1 (6.25)
Postmenopausal bleeding	2 (5.7)	1 (6.25)
No obvious discomfort and examination revealed abnormalities	16 (45.7)	4 (25)
Ascites, n (%)
Increased	5 (14.3)	2 (12.5)
Normal	30 (85.7)	14 (87.5)
Number of pregnancies [mean (range)], n (%)	2.86 (0-6)	3.31 (2-6)
FIGO stage, n (%)
I	16 (45.7)	—
II	4 (11.4)	—
III	9 (25.7)	—

¹Including appendicectomy, tubal sterilization, and cholecystectomy. FIGO: International Federation of Gynaecology and Obstetrics.